Olamkicept May Induce Response in IBD Patients
NEW YORK (Reuters Health) – Olamkicept, an interleukin (IL)-6 trans-signaling inhibitor, was well tolerated and induced a clinical response in […]
NEW YORK (Reuters Health) – Researchers have identified the process by which adherent-invasive Escherichia coli (AIEC) bacteria drive inflammation in […]ibd
Adherent-Invasive E. Coli Metabolism Drives Inflammation in Crohn’s Disease